PNC Financial Services Group
KBIO

PNC Financial Services Group’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

PNC Financial Services Group’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,000
Closed -$20K – 4910
2015
Q2 		$20K Hold
5,000
– – ﹤0.01% 3518
2015
Q1 		$20K Buy
5,000
+625
+14% +$2.8K ﹤0.01% 3521
2014
Q4 		$60K Buy
+4,375
New +$62.4K ﹤0.01% 2706

Other funds holding KBIO

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return

PNC Financial Services Group's KBIO Position: Q3 2015 in Review

PNC Financial Services Group sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q3 2015, closing a stake of 5,000 shares — an estimated $20K sold.

PNC Financial Services Group first reported a position in KBIO in Q4 2014 and held it in 3 quarters. The position peaked at $60K in Q4 2014. 14 funds tracked by Wall St. Rank hold KBIO as of Q3 2015.

  • PNC Financial Services Group reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q3 2015 after selling out during the quarter.
  • PNC Financial Services Group sold 5,000 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q3 2015, an estimated $20K.
  • PNC Financial Services Group first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q4 2014 and held it in 3 quarters.
  • PNC Financial Services Group's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $60K in Q4 2014.
  • 14 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q3 2015.

Based on PNC Financial Services Group's 13F filing for Q3 2015, filed 6 Nov 2015.